Full name
"APLEK" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0,3 | 0,2 | -35,6 |
Gross profit (loss) | 0 | 0,4 | 0,3 | -19,9 |
EBITDA | 0 | 0,4 | 0,3 | -28,9 |
Short time liabilities | 0,3 | 0,3 | 0,2 | -28,1 |
Other operating costs | 0 | 0 | 0 | 1484,9 |
Equity capital | 1,7 | 2 | 2,1 | 8,5 |
Operating profit (EBIT) | 0 | 0,3 | 0,2 | -37,6 |
Assets | 2 | 2,3 | 2,4 | 3,5 |
Net profit (loss) | 0 | 0,3 | 0,3 | -19,5 |
Cash | 1,2 | 1,3 | 1,5 | 17,6 |
Net income from sale | 0 | 5,5 | 5,7 | 3,4 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,2 | -27,4 |
Working assets | 1,9 | 2,1 | 2,2 | 5,9 |
Other income costs | 0 | 0 | 0 | -15,5 |
Depreciation | 0 | 0 | 0 | 151,8 |
% | % | % | p.p. | |
Profitability of capital | 0 | 15,9 | 11,8 | -4,1 |
Equity capital to total assets | 85,3 | 86,3 | 90,4 | 4,1 |
Gross profit margin | 6,4 | 5 | -1,4 | |
EBITDA Margin | 6,5 | 4,5 | -2 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 21 | 15 | -6 |
Current financial liquidity indicator | 6.667370796203613 | 6.652039051055908 | 9.789117813110352 | 3,1 |
Net dept to EBITDA | -3.501232385635376 | -5.790885925292969 | -2,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane